New Delhi: Zydus Lifesciences on Thursday said its consolidated net profit increased 38 per cent year-on-year to Rs 1,259 crore in the second quarter ended September 30, 2025, aided by robust sales growth in the US and India markets.

The Ahmedabad-based drug maker reported a net profit of Rs 911 crore in the July-September quarter of the last fiscal.

Revenue from operations rose to Rs 6,123 crore during the September quarter as against Rs 5,237 crore in the year-ago period, Zydus Lifesciences said in a statement.

The company said its board has approved raising up to Rs 5,000 crore via the issue of securities.

"Our strong performance this quarter reaffirms the power of our diversified business model and our execution capabilities across geographies and verticals," Zydus Lifesciences Man

See Full Page